Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$154M |
| 2 |
GE HealthCare
GEHC
|
+$103M |
| 3 |
Atlassian
TEAM
|
+$94.5M |
| 4 |
AXON
Axon Enterprise
AXON
|
+$21M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$322M |
| 2 |
Microsoft
MSFT
|
+$176M |
| 3 |
GE Aerospace
GE
|
+$115M |
| 4 |
Amazon
AMZN
|
+$79.9M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$77.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.45% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Cannae Holdings
CNNE
$675M
| $3.06M | ﹤0.01% |
151,494
-22,700
| -13% | -$503K |
|
1577
Par Pacific Holdings
PARR
$4.12B
| $3.04M | ﹤0.01% |
104,159
-12,000
| -10% | -$321K |
|
1578
3D Systems Corp
DDD
$601M
| $3.03M | ﹤0.01% |
283,050
-31,500
| -10% | -$321K |
|
1579
The Bancorp
TBBK
$2.82B
| $3.03M | ﹤0.01% |
108,700
-14,300
| -12% | -$454K |
|
1580
Enova International
ENVA
$6.52B
| $3.02M | ﹤0.01% |
67,900
-9,300
| -12% | -$422K |
|
1581
Palomar
PLMR
$3.37B
| $3.01M | ﹤0.01% |
54,500
-6,400
| -11% | -$343K |
|
1582
Hillman Solutions
HLMN
$1.71B
| $3M | ﹤0.01% |
356,800
+122,100
| +52% | +$1.06M |
|
1583
Virtus Investment Partners
VRTS
$1.14B
| $2.99M | ﹤0.01% |
15,700
-1,900
| -11% | -$384K |
|
|
EVBG
1584
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.99M | ﹤0.01% |
86,200
-9,700
| -10% | -$310K |
|
|
AVNS
1585
DELISTED
Avanos Medical
AVNS
| $2.99M | ﹤0.01% |
100,400
-11,800
| -11% | -$343K |
|
1586
Middlesex Water
MSEX
$1.11B
| $2.98M | ﹤0.01% |
38,162
-4,300
| -10% | -$347K |
|
1587
Ero Copper
ERO
$3.58B
| $2.98M | ﹤0.01% |
168,700
-18,500
| -10% | -$298K |
|
|
LAZR
1588
DELISTED
Luminar Technologies
LAZR
| $2.98M | ﹤0.01% |
30,580
-3,007
| -9% | -$316K |
|
1589
Gates Industrial Corporation Ltd.
GTES
$7B
| $2.96M | ﹤0.01% |
213,400
-25,200
| -11% | -$336K |
|
1590
nCino
NCNO
$2.26B
| $2.96M | ﹤0.01% |
119,600
-13,500
| -10% | -$356K |
|
|
NVEE
1591
DELISTED
NV5 Global
NVEE
| $2.96M | ﹤0.01% |
114,000
-13,600
| -11% | -$408K |
|
|
ALEX
1592
DELISTED
Alexander & Baldwin
ALEX
| $2.96M | ﹤0.01% |
156,620
-19,000
| -11% | -$360K |
|
1593
Provident Financial Services
PFS
$3.26B
| $2.96M | ﹤0.01% |
154,400
-18,300
| -11% | -$405K |
|
1594
Abercrombie & Fitch
ANF
$4.84B
| $2.96M | ﹤0.01% |
106,700
-12,800
| -11% | -$356K |
|
1595
Griffon
GFF
$4.8B
| $2.96M | ﹤0.01% |
92,400
-10,900
| -11% | -$399K |
|
1596
Horace Mann Educators
HMN
$2.1B
| $2.96M | ﹤0.01% |
88,300
-10,400
| -11% | -$372K |
|
1597
Weis Markets
WMK
$1.77B
| $2.95M | ﹤0.01% |
34,900
-4,100
| -11% | -$343K |
|
1598
Archrock
AROC
$5.85B
| $2.95M | ﹤0.01% |
302,200
-36,000
| -11% | -$353K |
|
1599
Marten Transport
MRTN
$1.24B
| $2.93M | ﹤0.01% |
139,975
-16,600
| -11% | -$353K |
|
1600
Celldex Therapeutics
CLDX
$3.35B
| $2.93M | ﹤0.01% |
81,400
-8,900
| -10% | -$384K |
|
Similar funds
Swiss National Bank's Q1 2023 Portfolio in Review
As of Q1 2023, Swiss National Bank held 2,715 positions worth $146B, up 4.7% from $139B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Swiss National Bank withdrew a net $4.63B in Q1 2023, closing 72 positions and reducing 2,517 holdings. Its most notable exit was STORE Capital Corporation, an estimated $19.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in L3Harris worth $148M.
- Swiss National Bank's largest Q1 2023 buy was L3Harris: 754,729 shares worth $148M.
- Swiss National Bank added most to Axon Enterprise in Q1 2023, an estimated $21M increase.
- Swiss National Bank's biggest Q1 2023 reduction was Apple, cutting an estimated $322M.
- Swiss National Bank fully exited STORE Capital Corporation in Q1 2023, selling an estimated $19.7M.
- Swiss National Bank's ten largest holdings make up 26% of its $146B portfolio in Q1 2023.
- Swiss National Bank opened 37 new positions and closed 72 in Q1 2023.
- Swiss National Bank's portfolio value rose 4.7% quarter-over-quarter to $146B.
Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.